Tag Archives for AstraZaneca; Pfizer; R&D; Pharmaceuticals

The ‘national interest’ test in the Pfizer – Astra Zeneca takeover bid

Valbona Muzaka

Patients and taxpayers should be central to any decision about the future of the pharmaceutical sector Pfizer’s withdrawal of its offer to buy AstraZeneca on Monday 26th May brought to a close a highly-politicised takeover proposal that could have been the largest foreign takeover in British business history. The political storm surrounding the bid was not surprising. Governments everywhere, even … Continue reading

24 June 2014 by
Categories: Economics, Employment, SPERI Comment | Tags: | 1 comment